These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24089534)

  • 1. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.
    Hillis GS; Welsh P; Chalmers J; Perkovic V; Chow CK; Li Q; Jun M; Neal B; Zoungas S; Poulter N; Mancia G; Williams B; Sattar N; Woodward M
    Diabetes Care; 2014; 37(1):295-303. PubMed ID: 24089534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.
    Ohkuma T; Jun M; Woodward M; Zoungas S; Cooper ME; Grobbee DE; Hamet P; Mancia G; Williams B; Welsh P; Sattar N; Shaw JE; Rahimi K; Chalmers J;
    Diabetes Care; 2017 Sep; 40(9):1203-1209. PubMed ID: 28684396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
    Welsh P; Woodward M; Hillis GS; Li Q; Marre M; Williams B; Poulter N; Ryan L; Harrap S; Patel A; Chalmers J; Sattar N
    Diabetes Care; 2014 Aug; 37(8):2202-10. PubMed ID: 24879844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
    Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
    Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
    Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
    Chen JR; Wang Q; Wu W; Zhang SJ
    Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus.
    Malachias MVB; Jhund PS; Claggett BL; Wijkman MO; Bentley-Lewis R; Chaturvedi N; Desai AS; Haffner SM; Parving HH; Prescott MF; Solomon SD; De Zeeuw D; McMurray JJV; Pfeffer MA
    J Am Heart Assoc; 2020 Oct; 9(19):e017462. PubMed ID: 32964800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303.
    Neuhold S; Pacher R; Hülsmann M
    Diabetes Care; 2014 Jun; 37(6):e152-3. PubMed ID: 24855180
    [No Abstract]   [Full Text] [Related]  

  • 15. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
    Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to comment on Hillis et al. The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic Peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes care 2014;37:295-303.
    Hillis GS; Welsh P; Chalmers J; Woodward M; Sattar N
    Diabetes Care; 2014 Jun; 37(6):e154. PubMed ID: 24855181
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.
    Haller PM; Jarolim P; Palazzolo MG; Bellavia A; Antman EM; Eikelboom J; Granger CB; Harrington J; Healey JS; Hijazi Z; Patel MR; Patel SM; Ruff CT; Wallentin L; Braunwald E; Giugliano RP; Morrow DA
    J Am Coll Cardiol; 2024 Oct; 84(16):1528-1540. PubMed ID: 39230543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis.
    Rehm M; Büchele G; Brenner RE; Günther KP; Brenner H; Koenig W; Rothenbacher D
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Hildebrandt P; Hess G; Parving HH; Pedersen O
    Diabetologia; 2005 Jan; 48(1):156-63. PubMed ID: 15619076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.